TWI382981B - 作為呼吸道融合病毒複製抑制劑之5-或6-經取代的苯并咪唑衍生物 - Google Patents

作為呼吸道融合病毒複製抑制劑之5-或6-經取代的苯并咪唑衍生物 Download PDF

Info

Publication number
TWI382981B
TWI382981B TW093139735A TW93139735A TWI382981B TW I382981 B TWI382981 B TW I382981B TW 093139735 A TW093139735 A TW 093139735A TW 93139735 A TW93139735 A TW 93139735A TW I382981 B TWI382981 B TW I382981B
Authority
TW
Taiwan
Prior art keywords
group
alkyl
formula
compound
substituted
Prior art date
Application number
TW093139735A
Other languages
English (en)
Chinese (zh)
Other versions
TW200531970A (en
Inventor
Jean-Francois Bonfanti
Koenraad Jozef Lodewijk Andries
Jerome Michel Claude Fortin
Philippe Muller
Frederic Marc Maurice Doublet
Christophe Meyer
Rudy Edmond Willebrords
Tom Valerius Josepha Gevers
Philip Maria Martha Bern Timmerman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of TW200531970A publication Critical patent/TW200531970A/zh
Application granted granted Critical
Publication of TWI382981B publication Critical patent/TWI382981B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW093139735A 2003-12-18 2004-12-20 作為呼吸道融合病毒複製抑制劑之5-或6-經取代的苯并咪唑衍生物 TWI382981B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03104806 2003-12-18

Publications (2)

Publication Number Publication Date
TW200531970A TW200531970A (en) 2005-10-01
TWI382981B true TWI382981B (zh) 2013-01-21

Family

ID=43646156

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093139735A TWI382981B (zh) 2003-12-18 2004-12-20 作為呼吸道融合病毒複製抑制劑之5-或6-經取代的苯并咪唑衍生物

Country Status (19)

Country Link
US (2) US20070093502A1 (ru)
EP (1) EP1697347B1 (ru)
JP (1) JP2007514719A (ru)
KR (1) KR101123055B1 (ru)
CN (1) CN1914196B (ru)
AR (1) AR046770A1 (ru)
AT (1) ATE499361T1 (ru)
AU (1) AU2004298459B2 (ru)
BR (1) BRPI0417273A (ru)
CA (1) CA2548793A1 (ru)
DE (1) DE602004031555D1 (ru)
DK (1) DK1697347T3 (ru)
HR (1) HRP20110313T1 (ru)
MX (1) MXPA06007111A (ru)
MY (1) MY142783A (ru)
RU (1) RU2369606C2 (ru)
SI (1) SI1697347T1 (ru)
TW (1) TWI382981B (ru)
WO (1) WO2005058874A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2612264C (en) * 2005-06-20 2014-09-23 Tibotec Pharmaceuticals Ltd. Heterocyclylaminoalkyl substituted benzimidazoles
PT2766359T (pt) 2011-10-14 2016-07-14 Ambit Biosciences Corp Compostos heterocíclicos e utilização dos mesmos como moduladores de recetores tirosina-cinase de tipo iii
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
RS60209B1 (sr) 2017-03-20 2020-06-30 Forma Therapeutics Inc Kompozicije pirolopirola kao aktivatori piruvat kinaze (pkr)
AU2018352695A1 (en) 2017-10-19 2020-05-28 Effector Therapeutics, Inc. Benzimidazole-indole inhibitors of Mnk1 and Mnk2
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r
US20220031671A1 (en) 2018-09-19 2022-02-03 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000612A2 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
WO2001000615A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
WO2001000611A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
WO2002090347A1 (en) * 2001-04-30 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Amide compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025621A (en) * 1975-01-09 1977-05-24 Purdy Clarence L Method of curing and providing immunity from viral infections
CA1140119A (en) 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4556660A (en) 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
KR100190299B1 (ko) 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
FR2833948B1 (fr) * 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000612A2 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
WO2001000615A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
WO2001000611A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
WO2002090347A1 (en) * 2001-04-30 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Amide compounds

Also Published As

Publication number Publication date
US8278455B2 (en) 2012-10-02
WO2005058874A1 (en) 2005-06-30
US20090062278A1 (en) 2009-03-05
HRP20110313T1 (hr) 2011-05-31
EP1697347A1 (en) 2006-09-06
DE602004031555D1 (de) 2011-04-07
AU2004298459B2 (en) 2011-03-17
BRPI0417273A (pt) 2007-03-27
AU2004298459A1 (en) 2005-06-30
CN1914196A (zh) 2007-02-14
CA2548793A1 (en) 2005-06-30
RU2369606C2 (ru) 2009-10-10
ATE499361T1 (de) 2011-03-15
CN1914196B (zh) 2012-01-25
KR101123055B1 (ko) 2012-04-12
MXPA06007111A (es) 2006-08-23
EP1697347B1 (en) 2011-02-23
AR046770A1 (es) 2005-12-21
JP2007514719A (ja) 2007-06-07
TW200531970A (en) 2005-10-01
SI1697347T1 (sl) 2011-06-30
RU2006125727A (ru) 2008-01-27
DK1697347T3 (da) 2011-06-06
KR20060127047A (ko) 2006-12-11
US20070093502A1 (en) 2007-04-26
MY142783A (en) 2010-12-31

Similar Documents

Publication Publication Date Title
RU2381224C2 (ru) Пиперидинаминобензимидазольные производные как ингибиторы репликации респираторного синцитиального вируса
BG65328B1 (bg) Бензимидазоли и имидазопиридини, фармацевтичен състав, който ги съдържа, метод за тяхното получаване и тяхното приложение
US8278455B2 (en) 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
KR101074333B1 (ko) 호흡기 세포융합 바이러스 복제 저해제로서의아미노-벤즈이미다졸 유도체
JP5078887B2 (ja) 呼吸器シンシチウムウイルスに活性をもつ、1−(2−アミノ−3−(置換アルキル)−3h−ベンズイミダゾイルメチル)−3−置換−1,3−ジヒドロ−ベンゾイミダゾル−2−オン
JP4915734B2 (ja) 呼吸器合胞体ウイルス複製阻害剤としてのアミノベンズイミダゾールおよびベンズイミダゾール
JP5094716B2 (ja) ヘテロシクリルアミノアルキル置換ベンズイミダゾール
JP5070207B2 (ja) 2−置換ベンズイミダゾール

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees